Are you Dr. Gressot?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 107 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
17323 Red Oak Dr
Houston, TX 77090Phone+1 281-440-5006Fax+1 281-440-6149
Summary
- Dr. Laurent Gressot, MD is an oncologist in Houston, Texas. He is currently licensed to practice medicine in Texas. He is affiliated with HCA Houston Healthcare Northwest, St. Luke's Health - The Woodlands Hospital, and HCA Houston Healthcare North Cypress.
Education & Training
University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1989 - 1993
Baylor College of MedicineResidency, Internal Medicine, 1987 - 1989
University of Geneva Faculty of MedicineClass of 1985
Certifications & Licensure
TX State Medical License 1989 - 2021- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- A Study Evaluating Talazoparib (BMN 673), a PARP Inhibitor, in Advanced and/or Metastatic Breast Cancer Patients With BRCA Mutation (EMBRACA Study) Start of enrollment: 2013 Oct 14
- Study of Efficacy and Safety of LEE011 in Postmenopausal Women With Advanced Breast Cancer.(MONALEESA-2) Start of enrollment: 2013 Dec 17
- Study of TH-302 or Placebo in Combination With Pemetrexed in Patients With Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2014 Jun 01
- Join now to see all
Publications & Presentations
PubMed
- 1714 citationsProspective Randomized Trial of Docetaxel Versus Best Supportive Care in Patients With Non–Small-Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyFrances A. Shepherd, Janet Dancey, Rodryg Ramlau, Karin Mattson, Richard J. Gralla
Journal of Clinical Oncology. 2000-05-10 - 97 citationsSunitinib Plus Paclitaxel Versus Bevacizumab Plus Paclitaxel for First-Line Treatment of Patients With Advanced Breast Cancer: A Phase III, Randomized, Open-Label TrialNicholas J. Robert, Mansoor N. Saleh, Devchand Paul, Daniele Generali, Laurent Gressot
Clinical Breast Cancer. 2011-04-01 - 4 citationsnab-paclitaxel/carboplatin induction in squamous NSCLC: longitudinal quality of life while on chemotherapy.Michael Thomas, David R. Spigel, Robert M. Jotte, Michael McCleod, Mark A. Socinski
Lung Cancer. 2017-10-30
Professional Memberships
- Member
